Recent Advances in HBV Reactivation Research

Figure 5

High anti-HBc and low anti-HBs at baseline predicted high risk of HBV reactivation (a: anti-HBc <6.41, anti-HBs<56.48, b: Anti-HBc <6.41, anti-HBs ≥56.48, c: Anti-HBc ≥6.41, anti-HBs<56.48, d: Anti-HBc ≥6.41, anti-HBs ≥56.48, p value ≤0.0001 (Long-rank)).